Fu'an Pharmaceutical announced on June 10 that its subsidiary Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. has obtained the “Drug Registration Certificate” for injectable azoxicillin sodium approved and issued by the State Drug Administration. Indications for injectable oxacillin sodium are: This product is only suitable for treating penicillinase-producing staphylococcal infections, including sepsis, endocarditis, pneumonia, and skin and soft tissue infections. It can also be used for mixed infections caused by Streptococcus pyogenes or pneumococci and penicillin-resistant staphylococci.

Zhitongcaijing · 06/10 08:25
Fu'an Pharmaceutical announced on June 10 that its subsidiary Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. has obtained the “Drug Registration Certificate” for injectable azoxicillin sodium approved and issued by the State Drug Administration. Indications for injectable oxacillin sodium are: This product is only suitable for treating penicillinase-producing staphylococcal infections, including sepsis, endocarditis, pneumonia, and skin and soft tissue infections. It can also be used for mixed infections caused by Streptococcus pyogenes or pneumococci and penicillin-resistant staphylococci.